HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gary A Ford Selected Research

4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)

1/2015Development of a decision analytic model to support decision making and risk communication about thrombolytic treatment.
6/2014Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.
11/2012Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis?
6/2012Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
9/2010Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).
2/2010Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
7/2009Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
12/2008Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).
1/2007Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gary A Ford Research Topics

Disease

40Stroke (Strokes)
08/2015 - 11/2003
9Hypertension (High Blood Pressure)
08/2015 - 10/2005
4Dementia (Dementias)
01/2015 - 04/2003
4Cerebral Hemorrhage
06/2014 - 12/2008
3Atrophy
01/2011 - 06/2007
2Pathologic Constriction (Stenosis)
06/2015 - 01/2013
2Myocardial Infarction
12/2014 - 02/2012
2Atrial Fibrillation
06/2014 - 11/2007
2Infarction
12/2012 - 12/2008
2Hemorrhage
06/2012 - 11/2007
2Pain (Aches)
05/2011 - 01/2004
1Carotid Stenosis (Carotid Artery Stenosis)
02/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Insulin Resistance
12/2014
1Transient Ischemic Attack
12/2014
1Acute Coronary Syndrome
03/2014
1Inflammation
03/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2014
1Thrombosis (Thrombus)
01/2013
1Body Weight (Weight, Body)
06/2012
1Deglutition Disorders (Dysphagia)
01/2009
1Cerebral Infarction
01/2009
1Heart Failure
12/2008
1Fatigue
01/2004
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2003
1Infection
11/2003
1Apnea
01/2002

Drug/Important Bio-Agent (IBA)

11Tissue Plasminogen Activator (Alteplase)FDA Link
05/2015 - 11/2003
94- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
01/2015 - 01/2007
4Lisinopril (Prinivil)FDA LinkGeneric
12/2014 - 01/2009
3Glucose (Dextrose)FDA LinkGeneric
08/2015 - 06/2012
3LDL CholesterolIBA
01/2015 - 09/2012
3Blood Glucose (Blood Sugar)IBA
06/2014 - 12/2008
3HomocysteineIBA
12/2011 - 08/2010
3Antihypertensive Agents (Antihypertensives)IBA
08/2010 - 01/2009
2Desmodus rotundus salivary plasminogen activator alpha 1IBA
06/2015 - 01/2013
2CalciumIBA
03/2014 - 10/2005
2Botulinum Toxins (Botulinum Toxin)IBA
12/2012 - 05/2011
2Type A Botulinum Toxins (Botulinum A Toxin)FDA Link
12/2012 - 05/2011
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2012 - 12/2008
2OxygenIBA
05/2012 - 01/2002
2Labetalol (Normodyne)FDA LinkGeneric
01/2010 - 01/2009
1lipoprotein cholesterolIBA
08/2015
1FibrinIBA
06/2015
1Plasminogen Activators (Plasminogen Activator)IBA
06/2015
1CholesterolIBA
01/2015
1pioglitazone (Actos)FDA Link
12/2014
12,4-thiazolidinedione (thiazolidinedione)IBA
12/2014
1Insulin (Novolin)FDA Link
12/2014
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
06/2014
1Vitamin DFDA LinkGeneric
03/2014
1Dopamine (Intropin)FDA LinkGeneric
01/2014
1Carbon MonoxideIBA
01/2014
14- (benzyloxy)- 2,6- diamino- 5- nitropyrimidineIBA
06/2013
1FibrinolysinFDA Link
01/2013
1LipidsIBA
01/2013
1phenylmethylpyrazoloneIBA
01/2013
1N 30IBA
01/2013
1HDL CholesterolIBA
09/2012
1C-Reactive ProteinIBA
09/2012
1Triglycerides (Triacylglycerol)IBA
09/2012
1CreatinineIBA
09/2012
1clopidogrel (Plavix)FDA Link
06/2012
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
03/2011
1Codon (Codons)IBA
03/2011
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2011
1Warfarin (Coumadin)FDA LinkGeneric
11/2007
1ximelagatran (Exanta)IBA
11/2007
1Alanine Transaminase (SGPT)IBA
11/2007
1ThrombinFDA Link
11/2007
1Complement System Proteins (Complement)IBA
10/2007
1Biological Markers (Surrogate Marker)IBA
08/2007
1candesartanIBA
06/2007
1AngiotensinsIBA
10/2005
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2005
1UK279276IBA
11/2003
1Cholinesterases (Cholinesterase)IBA
04/2003
1ButyrylcholinesteraseIBA
04/2003
1AcetylcholinesteraseIBA
04/2003
1Acetylcholine (Acetylcholine Chloride)FDA Link
04/2003

Therapy/Procedure

2Thrombolytic Therapy
06/2015 - 01/2007
2Activities of Daily Living (ADL)
01/2011 - 01/2004
1Exercise Therapy (Therapy, Exercise)
08/2015
1Endarterectomy (Thromboendarterectomy)
02/2015
1Therapeutics
01/2015
1Aftercare (After-Treatment)
06/2014
1Length of Stay
04/2014
1Emergency Treatment
01/2014
1Occupational Therapy (Therapy, Occupational)
01/2014
1Intravenous Infusions
01/2013